THE LEADING CIRCOVIRUS VACCINE IN THE U.S. MEETS THE LEADING MYCOPLASMA HYOPNEUMONIAE VACCINE.1 THE RESULT? COMPLETE CONFIDENCE IN A SINGLE DOSE.
- Control both PCV2 and Mycoplasma hyopneumoniae with one convenient dose
- Ingelvac® CircoFLEX-MycoFLEX™ is approved by APHIS to be mixed and administered as a single-dose, 2 mL injection to pigs 3 weeks of age or older
- Vaccinate pigs at weaning against two major swine diseases for protection to market
- Reduces stress on pigs and people
- Saves time and reduces labor costs

THE CONFIDENCE OF AN UNMATCHED SAFETY PROFILE
- Revolutionary ImpranFLEX™ adjuvant is aqueous-based and easy on pigs
- No tissue reaction like those associated with oil-based adjuvants
- Purified Circovirus Antigen (PCA™) used in Ingelvac CircoFLEX® is safe to pigs and virtually eliminates injection site lesions2,3
BEATS 2-DOSE PROGRAM IN FIELD TRIAL
A recent side-by-side field trial showed one 2 mL dose of Ingelvac CircoFLEX-MycoFLEX consistently outperformed an off-label combination of Circumvent® PCV and RespiSure-ONE® given in two, 1 mL (half doses) 3 weeks apart.4

- One-dose Ingelvac CircoFLEX-MycoFLEX mixture outperformed pigs vaccinated with the two-dose, off-label mixture
- Superior performance with a product USDA-licensed for mixing
- One injection vs. two means reduced labor costs, less stress on pigs and people
References
1. Beacon Report, May 2009.
2. Kolb, J., Diaz, E., AASV, March 2008.
3. Christmas, R., Kolb, J., Ingelvac CircoFLEX Symposium, September 2007, St. Paul, USA.
4. Technical Bulletin “Ingelvac CircoFLEX-MycoFLEX vs. Circumvent PCV & RespiSure-ONE”. Available from Boehringer Ingelheim Technical Services at 800-325-9167.
Circumvent is a registered trademark of Intervet Inc. or an affiliate. RespiSure-ONE is a registered trademark of Pfizer Inc.